Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Alimentary pharmacology and therapeutics

Results: 1-25/272

Authors: Talley, NJ Axon, A Bytzer, P Holtmann, G Lam, SK van Zanten, SV
Citation: Nj. Talley et al., Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998, ALIM PHARM, 13(9), 1999, pp. 1135-1148

Authors: Camilleri, M Mayer, EA Drossman, DA Heath, A Dukes, GE McSorley, D Kong, S Mangel, AW Northcutt, AR
Citation: M. Camilleri et al., Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist, ALIM PHARM, 13(9), 1999, pp. 1149-1159

Authors: Williams, MP Sercombe, JC Lawson, AJ Slater, E Owen, RJ Pounder, RE
Citation: Mp. Williams et al., The effect of omeprazole dosing on the isolation of Helicobacter pylori from gastric aspirates, ALIM PHARM, 13(9), 1999, pp. 1161-1169

Authors: Van der Hulst, RWM Lamouliatte, H Megraud, F Pounder, RE Stoltes, M Vaira, D Williams, M Tytgat, GNJ
Citation: Rwm. Van Der Hulst et al., Laser assisted ratio analyser C-13-urea breath testing, for the detection of H-pylori: a prospective diagnostic European multicentre study, ALIM PHARM, 13(9), 1999, pp. 1171-1177

Authors: Calleja, JL Albillos, A Moreno-Otero, R Rossi, I Cacho, G Domper, F Yebra, M Escartin, P
Citation: Jl. Calleja et al., Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia, ALIM PHARM, 13(9), 1999, pp. 1179-1186

Authors: Fabris, P Tositti, G Mazzella, G Zanetti, AR Nicolin, R Pellizzer, G Benedetti, P de Lalla, F
Citation: P. Fabris et al., Effect of ursodeoxycholic acid administration in patients with acute viralhepatitis: a pilot study, ALIM PHARM, 13(9), 1999, pp. 1187-1193

Authors: Dammann, HG Burkhardt, F Wolf, N
Citation: Hg. Dammann et al., The effects of oral rabeprazole on endocrine and gastric secretory function ill healthy volunteers, ALIM PHARM, 13(9), 1999, pp. 1195-1203

Authors: Wilkinson, SP Biddlestone, L Gore, S Shepherd, NA
Citation: Sp. Wilkinson et al., Regression of columnar-lined (Barrett's) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy, ALIM PHARM, 13(9), 1999, pp. 1205-1209

Authors: Khoury, RM Katz, PO Castell, DO
Citation: Rm. Khoury et al., Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers, ALIM PHARM, 13(9), 1999, pp. 1211-1214

Authors: Barclay, ML Begg, EJ Robson, RA Peters, WA Ketelbey, TW
Citation: Ml. Barclay et al., Lansoprazole pharmacokinetics differ in patients with oesophagitis compared to healthy volunteers, ALIM PHARM, 13(9), 1999, pp. 1215-1219

Authors: Greaves, RRSH Mulcahy, HE Patchett, SE Gorard, DA Fairclough, PD Alstead, EM Farthing, MJG
Citation: Rrsh. Greaves et al., Early experience with intrasphincteric botulinum toxin in the treatment ofachalasia, ALIM PHARM, 13(9), 1999, pp. 1221-1225

Authors: Peuhkuri, K Nevala, R Vapaatalo, H Moilanen, E Korpela, R
Citation: K. Peuhkuri et al., Ibuprofen augments gastrointestinal symptoms in lactose maldigesters during in lactose tolerance test, ALIM PHARM, 13(9), 1999, pp. 1227-1233

Authors: Rouzade, ML Anton, P Fioramonti, J Garcia-Villar, R Theodorou, V Bueno, L
Citation: Ml. Rouzade et al., Reduction of the nociceptive response to gastric distension by nitrate ingestion in rats, ALIM PHARM, 13(9), 1999, pp. 1235-1241

Authors: Ohno, T Katori, M Majima, M Saeki, T Boku, K Nishiyama, K Hayashi, H Saigenji, K
Citation: T. Ohno et al., Dilatation and constriction of rat gastric mucosal microvessels through prostaglandin EP2 and EP3 receptors, ALIM PHARM, 13(9), 1999, pp. 1243-1250

Authors: Savarino, V Vigneri, S
Citation: V. Savarino et S. Vigneri, Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection, ALIM PHARM, 13(9), 1999, pp. 1251-1251

Authors: Hoffman, JS
Citation: Js. Hoffman, Reply - Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection, ALIM PHARM, 13(9), 1999, pp. 1251-1252

Authors: Treiber, G Ammon, S Klotz, U
Citation: G. Treiber et al., 5-day H-pylori eradication, ALIM PHARM, 13(9), 1999, pp. 1252-1252

Authors: Neville, PM Moayyedi, P
Citation: Pm. Neville et P. Moayyedi, Reply - 5-day H. pylori eradication, ALIM PHARM, 13(9), 1999, pp. 1253-1253

Authors: Bokemeyer, B
Citation: B. Bokemeyer, Claversal dissolution, ALIM PHARM, 13(9), 1999, pp. 1253-1253

Authors: Trauner, M Graziadei, IW
Citation: M. Trauner et Iw. Graziadei, Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases, ALIM PHARM, 13(8), 1999, pp. 979-995

Authors: Cahill, A Lean, MEJ
Citation: A. Cahill et Mej. Lean, Review article: malnutrition and maltreatment - a comment on orlistat for the treatment of obesity, ALIM PHARM, 13(8), 1999, pp. 997-1002

Authors: Sonnenberg, A Inadomi, JM Becker, LA
Citation: A. Sonnenberg et al., Economic analysis of step-wise treatment of gastro-oesophageal reflux disease, ALIM PHARM, 13(8), 1999, pp. 1003-1013

Authors: Peters, HPF De Kort, AFCC Van Krevelen, H Akkermans, LMA Henegouwen, GPV Bol, E Mosterd, WL De Vries, WR
Citation: Hpf. Peters et al., The effect of omeprazole on gastro-oesophageal reflux and symptoms during strenuous exercise, ALIM PHARM, 13(8), 1999, pp. 1015-1022

Authors: van Rensburg, CJ Honiball, PJ Van Zyl, JH Grundling, HD Eloff, FP Spies, SK Simjee, AE Theron, I Fischer, R Louw, JA
Citation: Cj. Van Rensburg et al., Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis - a 2-year follow-up, ALIM PHARM, 13(8), 1999, pp. 1023-1028

Authors: Ho, KY Kang, JY Seow, A
Citation: Ky. Ho et al., Patterns of consultation and treatment for heartburn: findings from a Singaporean community survey, ALIM PHARM, 13(8), 1999, pp. 1029-1033
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>